 |
|
Interim Outcomes and Adverse Events among Drug-Resistant Tuberculosis Patients Treated with Bedaquiline in the Philippines
Vivian S. Lofranco,
Maria Rhoda A. Torres-Cervas,
Katherine A. Asence,
Khrizza Marianne A. Del Mundo,
Vincent M. Balanag,
Mary Rosary T. Santiago,
Anna Marie Celina G. Garfin
J. Tuberc. Res. Vol.10 No.2, April 24, 2022 DOI: 10.4236/jtr.2022.102005
Identifying Risk Factors for Pulmonary Tuberculosis Diagnosis Delays in Mali a West-African Endemic Country
Dianguina Soumare,
Bocar Baya,
Khadidia Ouattara,
Tenin Kanoute,
Cheick M. Sy,
Seydou Karembé,
Ibrahima Guindo,
Lamine Coulibaly,
Youssouf Kamian,
Aime P. Dakouo,
Fatoumata Sidibe,
Salif Koné,
Drissa Kone,
Oumar Yossi,
Gaoussou Berthe,
Yacouba Toloba
J. Tuberc. Res. Vol.10 No.1, March 25, 2022 DOI: 10.4236/jtr.2022.101004
C-Reactive Protein as a Triage Test in Guiding Who Should Get a Confirmatory Test for Pulmonary Tuberculosis Diagnosis among Adults: A Case-Control Proof-of-Concept Study from Urban Tanzania
Evarist Chiweka,
Thomas Maroa,
Hosiana Temba,
Joseph Ponera,
Sharifa Athumani,
Lujeko Kamwela,
Mohamed Sasamalo,
Rastard Naftari,
Mirambi Tito,
Francis Mhimbira,
Jerry Hella
J. Tuberc. Res. Vol.10 No.1, March 25, 2022 DOI: 10.4236/jtr.2022.101003
A Study on Pulmonary Tuberculosis and Risk Factors in New and Re-Treated Presumptive Patients at Wad Madani Tuberculosis Center, Sudan (2018-2019): A Cross-Sectional Study
Zeinab H. Alfaham,
Elhadi A. Ahmed,
Elamin M. Ibrahim,
Mohamed Soud Mohamed,
Ameer A. Mohamed,
Ayman Mahjob,
Mubarak A. Elshafia,
Bakri Y. M. Nour
J. Tuberc. Res. Vol.10 No.1, March 08, 2022 DOI: 10.4236/jtr.2022.101002